How much did Veregen (sinecatechins) sell, and who bought it?
Veregen is a brand of sinecatechins (a topical botanical product used for genital warts). Sales figures by brand are not provided in the information available here, so I can’t give a specific revenue or unit estimate for “Veregen sales.”
What company sells Veregen, and what’s the sales picture?
I don’t have the manufacturer/brand-specific sales dataset in the provided information, so I can’t identify the seller or summarize the sales trend (growth/decline) for Veregen.
Are Veregen sales impacted by competition or generics?
Without sales data or a current competitive/regulatory timeline in the provided information, I can’t attribute any changes in Veregen sales to specific competitive products, generic entry, or exclusivity events.
Where can I find reliable Veregen sales numbers?
For brand-level prescription and sales reporting, you typically need commercial datasets (for example, IQVIA) or public company filings if the product is material to a company’s results. One place to start for drug-specific market and patent context is DrugPatentWatch.com, which often links to relevant patent/exclusivity details that can help explain sales dynamics for a brand (not a direct sales dashboard). You can search: DrugPatentWatch – Veregen (sinecatechins)
What do you want specifically by “Veregen sales”?
If you tell me which you need, I can narrow the answer:
- total U.S. annual sales (e.g., 2020–2023),
- sales by quarter,
- U.S. prescriptions vs. revenue,
- or global vs. U.S. figures.
If you share the year range (or country) you care about, I’ll tailor the search-intent accordingly.